JP2010523626A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010523626A5 JP2010523626A5 JP2010502521A JP2010502521A JP2010523626A5 JP 2010523626 A5 JP2010523626 A5 JP 2010523626A5 JP 2010502521 A JP2010502521 A JP 2010502521A JP 2010502521 A JP2010502521 A JP 2010502521A JP 2010523626 A5 JP2010523626 A5 JP 2010523626A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- independently
- hal
- substituted
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 5
- -1 C1-C12 alkanoyl Chemical group 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 238000002059 diagnostic imaging Methods 0.000 claims description 4
- 125000004642 (C1-C12) alkoxy group Chemical group 0.000 claims 5
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims 5
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- 125000006710 (C2-C12) alkenyl group Chemical group 0.000 claims 2
- 125000006711 (C2-C12) alkynyl group Chemical group 0.000 claims 2
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 102000006815 folate receptor Human genes 0.000 claims 1
- 108020005243 folate receptor Proteins 0.000 claims 1
- 125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000000018 nitroso group Chemical group N(=O)* 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000011724 folic acid Substances 0.000 description 8
- 229960000304 folic acid Drugs 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000000376 autoradiography Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- NJEXHIONVCCPMH-PXYINDEMSA-N (2S)-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]-4-azidopentanedioic acid Chemical compound N(=[N+]=[N-])C(C(=O)O)C[C@@H](C(=O)O)NC(=O)C1=CC=C(NCC2=CN=C3N=C(N)NC(=O)C3=N2)C=C1 NJEXHIONVCCPMH-PXYINDEMSA-N 0.000 description 2
- AYMLQYFMYHISQO-QMMMGPOBSA-N (2s)-3-(1h-imidazol-3-ium-5-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CN=CN1 AYMLQYFMYHISQO-QMMMGPOBSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- 238000003820 Medium-pressure liquid chromatography Methods 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004896 high resolution mass spectrometry Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- VZLLWSOYYMFUKN-HSZRJFAPSA-N (2R)-2-(3-amino-3-oxopropyl)-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]-6-azido-3-oxohexanoic acid Chemical compound C1=CC(=CC=C1C(=O)N[C@](CCC(=O)N)(C(=O)CCCN=[N+]=[N-])C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N VZLLWSOYYMFUKN-HSZRJFAPSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- WIKLZASKGKBLQT-UHFFFAOYSA-N 1-azido-4-chlorobutane Chemical compound ClCCCCN=[N+]=[N-] WIKLZASKGKBLQT-UHFFFAOYSA-N 0.000 description 1
- NIDSRGCVYOEDFW-UHFFFAOYSA-N 1-bromo-4-chlorobutane Chemical compound ClCCCCBr NIDSRGCVYOEDFW-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- LTWDNZFPSXKPOZ-UHFFFAOYSA-N 4-[[1-(2-amino-4-oxo-1h-pteridin-6-yl)-2-(dimethylamino)ethenyl]-formylamino]benzoic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1C(=CN(C)C)N(C=O)C1=CC=C(C(O)=O)C=C1 LTWDNZFPSXKPOZ-UHFFFAOYSA-N 0.000 description 1
- 241000046326 Alitta Species 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N Histidine Chemical compound OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- DGYHPLMPMRKMPD-UHFFFAOYSA-N L-propargyl glycine Natural products OC(=O)C(N)CC#C DGYHPLMPMRKMPD-UHFFFAOYSA-N 0.000 description 1
- DGYHPLMPMRKMPD-BYPYZUCNSA-N L-propargylglycine Chemical compound OC(=O)[C@@H](N)CC#C DGYHPLMPMRKMPD-BYPYZUCNSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000003432 anti-folate effect Effects 0.000 description 1
- 229940127074 antifolate Drugs 0.000 description 1
- 238000011717 athymic nude mouse Methods 0.000 description 1
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000006309 butyl amino group Chemical group 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000004980 dosimetry Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 238000012632 fluorescent imaging Methods 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000004052 folic acid antagonist Substances 0.000 description 1
- 239000012216 imaging agent Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 238000013421 nuclear magnetic resonance imaging Methods 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- QOFFJEBXNKRSPX-ZDUSSCGKSA-N pemetrexed Chemical compound C1=N[C]2NC(N)=NC(=O)C2=C1CCC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 QOFFJEBXNKRSPX-ZDUSSCGKSA-N 0.000 description 1
- 229960005079 pemetrexed Drugs 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 230000003439 radiotherapeutic effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229910052702 rhenium Inorganic materials 0.000 description 1
- WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229910052713 technetium Inorganic materials 0.000 description 1
- GKLVYJBZJHMRIY-UHFFFAOYSA-N technetium atom Chemical compound [Tc] GKLVYJBZJHMRIY-UHFFFAOYSA-N 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07105980.2 | 2007-04-11 | ||
| EP07105980 | 2007-04-11 | ||
| PCT/EP2008/054409 WO2008125618A1 (en) | 2007-04-11 | 2008-04-11 | Folate-conjugates and corresponding metal-chelate complexes for use in diagnostic imaging and radiotherapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014099667A Division JP5876527B2 (ja) | 2007-04-11 | 2014-05-13 | 診断用画像及び放射線治療用の葉酸複合体及び対応する金属キレート錯体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010523626A JP2010523626A (ja) | 2010-07-15 |
| JP2010523626A5 true JP2010523626A5 (cg-RX-API-DMAC7.html) | 2014-01-16 |
| JP5710246B2 JP5710246B2 (ja) | 2015-04-30 |
Family
ID=39683755
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010502521A Expired - Fee Related JP5710246B2 (ja) | 2007-04-11 | 2008-04-11 | 診断用画像及び放射線治療用の葉酸複合体及び対応する金属キレート錯体 |
| JP2014099667A Expired - Fee Related JP5876527B2 (ja) | 2007-04-11 | 2014-05-13 | 診断用画像及び放射線治療用の葉酸複合体及び対応する金属キレート錯体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014099667A Expired - Fee Related JP5876527B2 (ja) | 2007-04-11 | 2014-05-13 | 診断用画像及び放射線治療用の葉酸複合体及び対応する金属キレート錯体 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20100143249A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2146995A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5710246B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR101605426B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101646672B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2008237935B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2670385C (cg-RX-API-DMAC7.html) |
| EA (1) | EA200901344A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL201250A0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008125618A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200903483B (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101605426B1 (ko) * | 2007-04-11 | 2016-03-22 | 메르크 앤드 씨에 | 진단 이미징 및 방사선치료에 사용하기 위한 폴레이트-컨쥬게이트 및 대응하는 금속-킬레이트 착물 |
| US8236284B1 (en) * | 2008-04-02 | 2012-08-07 | University Of Central Florida Research Foundation, Inc. | Multimodal, multifunctional polymer coated nanoparticles |
| FR2942227B1 (fr) * | 2009-02-13 | 2011-04-15 | Guerbet Sa | Utilisation de tampons pour la complexation de radionucleides |
| WO2011084571A2 (en) | 2009-12-16 | 2011-07-14 | Mallinckrodt Inc. | Azide derivatives for phototherapy |
| KR102036199B1 (ko) * | 2011-08-17 | 2019-10-24 | 메르크 앤드 씨에 | 알부민-결합 개체들의 폴레이트 공액체들 |
| PL2864329T3 (pl) | 2012-05-08 | 2019-03-29 | Merck & Cie | 18f-znakowane analogi folianowe/antyfolianowe |
| WO2016127023A1 (en) * | 2015-02-06 | 2016-08-11 | Cempra Pharmaceuticals, Inc. | 4-azidobutylamines and processes for preparing |
| WO2020256210A1 (ko) | 2019-06-20 | 2020-12-24 | 주식회사 쿼드마이너 | 네트워크 포렌식 시스템 및 이를 이용한 네트워크 포렌식 방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6093382A (en) * | 1998-05-16 | 2000-07-25 | Bracco Research Usa Inc. | Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| EP1389209B1 (en) | 2001-04-24 | 2009-04-08 | Purdue Research Foundation | Folate mimetics and folate-receptor binding conjugates thereof |
| DK2258401T3 (da) * | 2002-05-06 | 2014-10-13 | Endocyte Inc | Folat-receptor targetede billeddannelsesmidler |
| CA2524222C (en) * | 2003-04-29 | 2012-02-07 | Roger Alberto | N.epsilon. and/or n.alpha. derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3(co)3]+ by fac coordination |
| US9265746B2 (en) * | 2006-05-31 | 2016-02-23 | Merck & Cie | Method for cell-specific targeting |
| KR101605426B1 (ko) * | 2007-04-11 | 2016-03-22 | 메르크 앤드 씨에 | 진단 이미징 및 방사선치료에 사용하기 위한 폴레이트-컨쥬게이트 및 대응하는 금속-킬레이트 착물 |
-
2008
- 2008-04-11 KR KR1020097023300A patent/KR101605426B1/ko not_active Expired - Fee Related
- 2008-04-11 AU AU2008237935A patent/AU2008237935B2/en not_active Ceased
- 2008-04-11 WO PCT/EP2008/054409 patent/WO2008125618A1/en not_active Ceased
- 2008-04-11 JP JP2010502521A patent/JP5710246B2/ja not_active Expired - Fee Related
- 2008-04-11 US US12/595,147 patent/US20100143249A1/en not_active Abandoned
- 2008-04-11 EA EA200901344A patent/EA200901344A1/ru unknown
- 2008-04-11 CN CN200880002741.6A patent/CN101646672B/zh not_active Expired - Fee Related
- 2008-04-11 KR KR1020157034215A patent/KR20150140415A/ko not_active Withdrawn
- 2008-04-11 EP EP08736122A patent/EP2146995A1/en not_active Withdrawn
- 2008-04-11 CA CA2670385A patent/CA2670385C/en not_active Expired - Fee Related
-
2009
- 2009-05-20 ZA ZA200903483A patent/ZA200903483B/xx unknown
- 2009-09-30 IL IL201250A patent/IL201250A0/en not_active IP Right Cessation
-
2014
- 2014-05-13 JP JP2014099667A patent/JP5876527B2/ja not_active Expired - Fee Related
-
2016
- 2016-11-22 US US15/358,787 patent/US20170128599A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010523626A5 (cg-RX-API-DMAC7.html) | ||
| TWI245764B (en) | Amyloid plaque aggregation inhibitors and diagnostic imaging agents | |
| JP7326622B2 (ja) | Ｅｒｋ阻害剤としてのスピロ系化合物およびその使用 | |
| KR101639268B1 (ko) | １８ ｆ-표지된 폴레이트 | |
| AU2013258027B2 (en) | 18F-labelled follate/antifolate analogues | |
| JP5876527B2 (ja) | 診断用画像及び放射線治療用の葉酸複合体及び対応する金属キレート錯体 | |
| CN116249698A (zh) | 异色满类化合物 | |
| CN118271393B (zh) | 一种靶向fap的二聚化合物及其探针和应用 | |
| CN102177160B (zh) | 作为pet放射性示踪剂的18f-标记叶酸 | |
| US20100056533A1 (en) | 18f-labelled folates | |
| CN101885744B (zh) | 99mTc标记肼基烟酰胺基-蝶酰赖氨酸配合物的制备方法 | |
| EP2643301B1 (fr) | Complexe de technetium 99m en tant qu'outil de diagnostic in vivo des tumeurs cancereuses | |
| CN101293864A (zh) | 一种与脑Aβ斑块具有亲和力的化合物及其制备方法和应用 | |
| JP5179811B2 (ja) | ウラシル化合物又はその塩、これらを有効成分として含有するイメージング剤、およびこれらを有効成分として含有する腫瘍診断をするためのイメージング剤 | |
| JP2021528461A (ja) | 黒色腫の治療用放射性化合物およびこの用途 | |
| CN120136960A (zh) | 一种成纤维细胞活化蛋白靶向化合物、其核素标记物、包含其的药物组合物和应用 | |
| US6384232B1 (en) | Methods of synthesizing heteroatom-bearing ligands and intermediate used thereof | |
| JP2009161477A (ja) | 腫瘍イメージング剤 | |
| JP2003306489A (ja) | ピロールピリジン誘導体放射性化合物 | |
| HK1138571B (en) | Folate-conjugates and corresponding metal-chelate complexes for use in diagnostic imaging and radiotherapy |